Bernstein says Nike stock now 'de-risked', buy on post-earnings dip

Nike reported fiscal Q1 revenue of $11.2 billion, down 4% year over year and worse than expected, while EPS of $0.48 beat consensus. Bernstein analyst Aneesha Sherman views management's assertion that estimates are now de-risked as credible and recommends buying the shares following their post-earnings decline.

Analysis

The key underwriting question is whether Nike’s earnings beat reflects a sustainable gross-margin reset or simply lower discretionary spending and timing benefits. A credible revenue trough would support multiple stabilization, but the equity will remain constrained until management demonstrates that brand heat and wholesale sell-through are improving without incremental promotional intensity. The next 1-3 months are likely driven more by inventory, markdown, and forward-order commentary than by the reported EPS variance.

Competitive risk is asymmetric: weak Nike demand creates shelf space and consumer trial opportunities for ONON, DECK, CROX, HOKA-parent DECK, and Adidas (ADDYY), particularly in running and performance categories where product innovation—not broad macro demand—determines share. Nike’s scale gives it bargaining leverage with key wholesale accounts, but a push to clear product can pressure category pricing and retailer margins at FL, DKS and JD Sports (JD.L). A recovery in Nike’s wholesale channel would therefore be constructive for FL/JD inventory turns, while an extended direct-to-consumer reset could favor those retailers through improved allocation and promotional support.

Contrarian view: the market may be too quick to capitalize a single-quarter EPS beat as evidence that downside is fully contained. Nike needs sequential improvement in full-price sell-through and evidence that China and lifestyle footwear are no longer detracting; otherwise, consensus FY earnings still face revision risk despite a lower starting revenue base. Conversely, if inventory declines faster than sales and gross margin holds despite lower promotions, the stock can rerate before revenue turns, making the next guidance update the decisive catalyst.

Thesis falsification: avoid treating the drawdown as a durable entry if management cuts FY revenue/EBIT guidance again, inventories rise sequentially, or gross margin misses on discounting. Confirmation would be two consecutive quarters of improving wholesale orders, reduced markdowns, and stable-to-rising gross margin.

Key Decisions for Investors

• Watch, do not immediately add NKE solely on the post-earnings decline. Initiate only after the next update confirms sequential inventory reduction and no further FY guidance reset; target a 6-12 month recovery trade, with exit on renewed margin compression or a second guidance cut.
• Express a relative-value recovery view via long NKE / short XRT or a basket of discretionary retail ETFs over 3-6 months. This isolates company-specific margin and brand normalization from a broad consumer slowdown; size modestly until wholesale-order trends validate the turn.
• For a more defensive read-through, monitor FL and JD.L inventory and gross-margin commentary over the next 1-2 earnings cycles. Improved Nike allocations with lower retailer markdowns would support long FL/JD tactical positions; rising clearance activity would instead favor avoiding footwear retail exposure.
• Use ONON and DECK as competitive-warning indicators over the next two quarters: continued acceleration in their North American footwear growth while NKE remains promotional would invalidate a Nike-share-recovery thesis and argue against averaging down.